Home›Companies›Healthcare›Aruka Bio

Aruka Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 24, 2024·Suggest an edit

About Aruka Bio

Aruka Bio is a private company based in Princeton, New Jersey, incorporated in 2023 in Delaware. It has reported $3,554,000 raised in two offerings on Form D since September 2023. Its chief executive is Nareshkumar Jain, Ph.d..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 17, 2024Apr 24, 2024$3,550,000fully sold7$507KEquityRule 506(b)Form D ↗
Aug 25, 2023Sep 7, 2023$4,000of $5.5M target1$4,000EquityRule 506(b)Form D ↗
Total, two offerings$3,554,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aruka Bio's Form D filed Apr 24, 2024.

SM
Siddhartha Mukherjee
Executive officer and director
ND
Nareshkumar Jain, Ph.d.
President/ceo and director

Earlier filings also listed Nareshkumar Jain (executive officer and director, last listed Sep 2023).

Sources

  1. SECARUKA BIO, INC. filing history